Nanoslit DNA Stretching Using Debye-Length Confinement

Solution Overview

Problem

Current DNA sequencing approaches struggle with redundant sequence data from short analyte molecules, making it difficult to assemble human or cancer genomes, and limited in assessing genomic alterations due to the lack of effective methods to stretch nucleic acid molecules close to their contour length.

Innovation Solution

A microfluidic device and method that uses a nanoslit between microchannels with an ionic buffer to position nucleic acid molecules in a 'dumbbell' configuration, leveraging electrostatic and hydrodynamic properties to achieve a summed Debye length greater than or equal to the nanoslit dimensions, thereby stretching the central portion of the molecule.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If nanochannels with dimensions smaller than molecular persistence length are used to stretch DNA molecules close to contour length, then stretching precision is improved, but device complexity increases

Engineering Contradiction:
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent changes the key parameter from nanoscale channel dimensions (smaller than persistence length) to microscale channel dimensions (larger than persistence length). This parameter change allows achieving effective DNA stretching without requiring fabrication of extreme nanoconfinement devices, thereby reducing device complexity while maintaining stretching precision through the dumbbell configuration mechanism.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent introduces an intermediary mechanism - the dumbbell configuration formed by electrostatic interactions between DNA and channel walls - that mediates the stretching process. This intermediary allows DNA to be stretched to near-contour length without direct mechanical confinement at the nanoscale, avoiding the need for complex nanofabrication while achieving the desired stretching effect.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Manufacturing precision

If extreme nanoconfinement devices are fabricated to elongate DNA molecules close to molecular contour length, then stretching precision is improved, but ease of operation deteriorates

Engineering Contradiction:
Core Design Contradiction:
Manufacturing precisionVSEase of operation

Solution Approach 1:

The patent changes the operational parameter from nanoscale confinement (requiring complex loading procedures) to microscale confinement with controlled electrostatic conditions. This parameter change simplifies the loading and operation process while maintaining the ability to achieve near-contour length stretching through the dumbbell configuration mechanism.

Inventive Principle:
Principle #35Parameter changes

3Productivity

If short analyte molecules are used for sequencing, then productivity is improved, but measurement precision deteriorates due to redundant sequence data

Engineering Contradiction:
Core Design Contradiction:
ProductivityVSMeasurement precision

Solution Approach 1:

The patent segments the DNA molecule into distinct regions - a confined central portion within the microchannel that provides unique spatial positioning and flanking unconfined portions that form the dumbbell configuration. This segmentation allows the entire genome to be analyzed in large contiguous segments rather than short fragments, improving both productivity and measurement precision by eliminating redundant sequence data while maintaining high throughput.

Inventive Principle:
Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method achieves significant stretching of nucleic acid molecules, enhancing their relaxation time and facilitating genomic analysis by presenting them in a fully stretched conformation, overcoming previous limitations of device complexity and molecular loading processes.

Implementation Method 1

An ionic strength of the ionic buffer and electrostatic or hydrodynamic properties of the nanoslit and the nucleic acid molecule can combine to provide a summed Debye length that is greater than or equal to a nanoslit height or a nanoslit width

Methodology Applied
Scientific EffectDebye length: Debye-Falkenhagen Effect

Implementation Method 2

An ionic strength of the ionic buffer and electrostatic or hydrodynamic properties of the nanoslit and the nucleic acid molecule can combine to provide a summed Debye length

Methodology Applied
Scientific EffectElectrostatic interaction: Electrostatics

Implementation Method 3

An ionic strength of the ionic buffer and electrostatic or hydrodynamic properties of the nanoslit and the nucleic acid molecule can combine to provide a summed Debye length

Methodology Applied
Scientific EffectHydrodynamic interaction:

Data Source

PatentUS12618801B2System and method for presenting large DNA molecules for analysis
Publication Date: 2026.05.05
  • US12618801B2 patent drawing
  • US12618801B2 patent drawing
  • US12618801B2 patent drawing

AI summary

Systems and methods for presenting nucleic acid molecules for analysis are provided. The nucleic acid molecules have a central portion that is contained within a nanoslit. The nanoslit contains an ionic buffer. The nucleic acid molecule has a contour length that is greater than a nanoslit length of the nanoslit. An ionic strength of the ionic buffer and electrostatic or hydrodynamic properties of the nanoslit and the nucleic acid molecule combining to provide a summed Debye length that is greater than or equal to the smallest physical dimension of the nanoslit.